Heritage Cannabis Reports Q2 2023 Financial Results, Achieving Continued Gross Margin Growth for the Quarter
“We are very pleased to have achieved gross margin growth once again this quarter, despite the lack of much needed regulatory changes within the industry in
Selected Financial Highlights
Selected financial highlights for the three- and six-month periods ended April 30, 2023, and April 30, 2022, include the following:
|
Three months ended |
Six months ended |
||
(in $CDN) |
Apr 30, 2023
|
Apr 30, 2022
|
Apr 30, 2023
|
Apr 30, 2022
|
|
||||
Gross revenue |
10,165,939 |
10,452,313 |
19,612,934 |
20,048,454 |
Net revenue (net of excise tax) |
7,379,043 |
7,491,184 |
13,702,455 |
14,032,395 |
|
|
|
|
|
Cost of sales |
4,074,385 |
4,306,378 |
8,346,636 |
8,962,828 |
Gross margin |
3,304,658 |
3,184,806 |
5,355,819 |
5,069,567 |
|
|
|
|
|
General and administrative expenses |
5,051,952 |
4,084,500 |
9,699,499 |
9,244,998 |
Other Income (Expenses) |
(375,704) |
(185,513) |
(553,556) |
8,367,299 |
Comprehensive Income (Loss) |
(1,958,047) |
(500,614) |
(4,721,007) |
5,756,599 |
Q2 2023 Financial Highlights
-
The Company reported gross revenue of
for the three months ended April 30, 2023, a decrease of$10,165,939 compared to the gross revenue of$286,374 for the three months ended April 30, 2022. The decrease in gross revenue was primarily due to a continued rotation of the Company’s SKUs at the provincial board level particularly through its flower vertical which was down$10,452,313 17% in the current quarter compared to the prior quarter while the impact of both the Thrifty launch and Adults Only brands are between load-in and initial replenishment stage and didn’t have a full impact on the quarter end results.
-
For the six months ended April 30, 2023, the Company reported gross revenue of
, a decrease of$19,612,934 compared to the gross revenue of$435,520 for the six months ended April 30, 2022. The decrease in gross revenue was primarily by a reduction in tincture sales and vape sales which were down$20,048,454 14% and4% year over year and minimal contribution from the new brands which partially offset the SKU rotation.
-
Cost of sales for the three months ended April 30, 2023, was
, a decrease of$4,074,385 , compared to$231,993 for the three months ended April 30, 2022. The decrease represented a$4,306,378 1% improvement, as a percentage of sales, in the current period. As stated in previous quarters, the Company is continuously reviewing its processes for optimization either on the manufacturing side or through material costing which continued to positively impact the results in the current quarter.
-
For the six months ended April 30, 2023, cost of sales was
, a decrease of$8,346,636 , compared to$616,192 for the six months ended April 30, 2022. The decrease represented a$8,962,828 2% improvement, as a percentage of sales, in the current period. The improvement was a result of continued production refinements to enable more efficient production.
-
Gross margin for the three months ended April 30, 2023 was
compared to gross margin of$3,304,658 for the three months ended April 30, 2022. The increase in gross margin of$3,184,806 was primarily a result of improved production efficiencies in addition to a lower excise rate of$119,852 27.4% compared to28.3% in the prior period which was driven by increased bulk B2B sales which provides less exposure to excise taxes.
-
For the six months ended April 30, 2023, gross margin was
compared to gross margin of$5,355,819 for the six months ended April 30, 2022. The increase in gross margin of$5,069,567 was primarily a result of improved production efficiencies over the course of the year given excise was flat period over period.$286,252
-
For the three months ended April 30, 2023, the Company recorded a comprehensive loss of
or$1,958,047 loss per share compared to a comprehensive loss of$0.00 or$500,614 loss per share for the three months ended April 30, 2022. The increase in comprehensive loss of$0.00 during this period was attributable to higher interest costs as a result of rising interest rates and unrealized losses on derivative liabilities as a result of revaluations.$1,457,433
-
For the six months ended April 30, 2023, the Company recorded a comprehensive loss of
or$4,721,007 loss per share compared to a comprehensive income of$0.01 or$5,756,599 income per share for the six months ended April 30, 2022. The increase in comprehensive loss of$0.01 during the period was driven by three key factors: the unrealized gain the prior period relating to various unachieved acquisition milestones of$10,477,606 , the gain related to the sale of Stanley Park digital of$8,415,429 and the impact of rising interest rates which increased the interest expense by$608,000 during this period.$205,000
Q2 2023 Growth, Operational, and Corporate Highlights
-
On February 6, 2023, the Company appointed Eoin Hegarty as Chief Operating Officer, and Cory Larsen as Chief Commercial Officer. Dan Phaure has retained his position as Chief Financial Officer, following his resignation from the role of Chief Operating Officer. Both Mr. Hegarty and Mr. Larsen are current employees of Heritage, and their promotions follow on their achievements in advancing the Company’s strategy to not only successfully expand across
Canada , but also in Heritage’s entry intothe United States .
- Heritage has transitioned to a true product and brand company, creating “forever SKUs” that have seen solid uptake in the Canadian cannabis market. Now with in-house expertise in production, manufacturing, white labelling, pick and pack, and distribution, Heritage has developed several relationships to leverage this expertise. The Company has entered distribution relationships with a number of well-known companies and brands including Aurora Medical, Canopy Growth Corp, Violet Tourist, OMG, White Rabbit, Panacea, North 40, and Mad Hatter. To extend Heritage’s capabilities in the cannabis market, the Company will consider opportunities to extend in other areas of the supply chain that will provide vertical integration and positively impact margins.
-
On March 6, 2023, Heritage announced the receipt of a purchase order from a well-established Australian company for the supply of 15,000 units of Live Resin concentrate vape cartridges. Heritage recently received import permits allowing the Company to ship products to this growing market. The Australian market, while still in its infancy as a medical cannabis market, Heritage is the first company to ship Live Resin to
Australia
-
On March 8, 2023, Heritage announced that the
Missouri facility effectively began in the state ofMissouri . Heritage, through its relationship with Como Health LLC, doing business as 3Fifteen Primo Cannabis (“3Fifteen”), has had products in market since legalization at 3Fifteen’s medical dispensaries inMissouri , including 12 stock keeping units (“SKUs”) on shelves. Already seeing strong sales on the medical side, theMissouri operation is poised to capture a piece of the newly minted recreational market.
-
On March 13, 2023, Heritage announced that it has met the regulatory requirements and achieved approval from the Brazil Health Authority (ANVISA) to import its first formulated CBD product into
Brazil . Heritage has also achieved stability on two additional products that are awaiting final approval. In 2021, Health Canada granted Heritage with the first ever license to export cannabis products fromCanada toBrazil , and Heritage successfully shipped products to enter the testing phase with ANVISA.
-
Following the end of the second quarter, Heritage announced plans to enter the recreational cannabis market in
New York , with RAD branded vape and concentrate products becoming available toNew York consumers this summer. Heritage continues to target legalized markets in theU.S. with an asset light model and has signed a manufacturing and distribution agreement with a local partner that will primarily produce and sell products using Heritage’s innovative formulations and flavours that have achieved success in other markets. The initial launch will be 6 SKUs and Heritage plans to add additional RAD products including live resin, rosin, and infused pre-rolls, as well as expand product offerings with additional Heritage brands.
Financial Statements
The consolidated financial statements of the Company as at and for the three- and six-month periods ended April 30, 2023, and accompanying management's discussion and analysis have been filed with the securities regulators and are available on SEDAR at www.sedar.com under the Company’s issuer profile.
About Heritage Cannabis Holdings Corp.
Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.
“David Schwede”
David Schwede
CEO
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements.
An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading "Risks and Uncertainties" in the Company's annual management discussion and analysis for the year ended October 31, 2022, and dated February 28, 2023. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.
In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230628002868/en/
For more information contact:
Kelly Castledine
Tel: 647-660-2560
kcastledine@heritagecann.com
Source: Heritage Cannabis Holdings Corp.